Exploring Mechanisms of Ephx2 in Treating Atherosclerosis Using Independent Cascade Model and Adverse Outcome Pathways
By defining the AS network and corresponding RD, this study elucidated potential mechanisms by which Ephx2 affects AS through specific KEGG pathways, AOPs, and target genes. These findings enhanced the understanding of AS pathogenesis and highlighted potential targets like Mapk3 for developing therapeutic strategies in AS prevention and treatment.
Authors
- Wei Pang (ORCID: https://orcid.org/0000-0001-6328-7043)
- C. Zhang
- Yong Chen (ORCID: https://orcid.org/0000-0002-3520-1991)
- Yong Dai (ORCID: https://orcid.org/0000-0003-1260-4234)
- Bo Cao (ORCID: https://orcid.org/0000-0002-9324-261X)
- Jinbing An (ORCID: https://orcid.org/0000-0002-2784-1390)
Institutions
- Peking University (CN)
- Jiangxi Normal University (CN)
Publication Details
- Journal
- Combinatorial Chemistry & High Throughput Screening
- Published
- 2025-03-27
- DOI
- https://doi.org/10.2174/0113862073345542250220051427
- Primary Topic
- Eicosanoids and Hypertension Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00